Plasma microRNA signature as biomarker for disease progression in frontotemporal dementia and amyotrophic lateral sclerosis.

Authors :: Dewan R
Traynor BJ
Source :: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2021 May; Vol. 92 (5), pp. 458. Date of Electronic Publication: 2021 Mar 15.
Publication Year :: 2021
Abstract: Competing Interests: Competing interests: BJT holds US, EU and Canadian patents on the clinical testing and therapeutic intervention for the hexanucleotide repeat expansion of C9orf72. BJT is an editorial board member for JNNP and Neurobiology of Aging and is an associate editor for Brain.

Subjects :: Biomarkers
Disease Progression
Humans
Amyotrophic Lateral Sclerosis diagnosis
Amyotrophic Lateral Sclerosis genetics
Frontotemporal Dementia diagnosis
Frontotemporal Dementia genetics
MicroRNAs genetics

Full Text Access

Tools